U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT06967961) titled 'Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers' on May 05.
Brief Summary: A prospective, proof-of-concept pilot study in patients with metastatic cancers (9 types of cancers are studied) treated at the IUCT-O or possibly in other institutions. Eligible patients will be selected and informed of this study during a medical consultation for their cancer by medical oncologists. Then, with the patient's consent and before the start of anti-cancer treatment (whatever the line), a blood sample will be taken to detect DP-circulating cells by 2 different methods of analysis.
Each p...